JILLIAN FINCHER: Open Payments
NPI 1073145207 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 42 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $416 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 4 | $184 |
| Novo Nordisk Inc | 6 | $120 |
| ABBVIE INC. | 4 | $75 |
| Lilly USA, LLC | 4 | $71 |
| PFIZER INC. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Amgen Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Radius Health, Inc. | 1 | $29 |
Products named: TZIELD, Wegovy, MOUNJARO, PREVNAR 20, QULIPTA, UBRELVY, AIRSUPRA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
